← FDA Drug Approvals (Drugs@FDA)
CISATRACURIUM BESYLATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2023-04-19
Drug application
- FDA Application #
ANDA203079- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- CISATRACURIUM BESYLATE
- Generic name
- CISATRACURIUM BESYLATE
- Active ingredients
- CISATRACURIUM BESYLATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- HIKMA
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- First approval
- 2023-04-19
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown